Mindfulness in Adolescents With Obesity
19 de marzo de 2021 actualizado por: Elizabeth Cotter, American University
Examining the Feasibility of a Brief Adjunctive Mindfulness Intervention for Adolescents With Obesity
The goal of this study is to conduct a single arm open trial to examine the feasibility of a brief, adjunctive mindfulness intervention tailored to the needs of adolescents with severe obesity.
Descripción general del estudio
Estado
Terminado
Condiciones
Intervención / Tratamiento
Descripción detallada
The purpose of this study is to examine whether it is feasible to integrate a brief, adjunctive mindfulness intervention with the standard medical management of obesity in adolescents with severe obesity. Mindfulness refers to the experience of paying attention to the present moment in a nonjudgmental manner. Mindfulness training enhances one's ability to cope with negative emotions and one's awareness of decision-making processes and internal experiences.
The proposed study has two specific aims: 1) to conduct a single arm open trial to examine the feasibility and acceptability of the mindfulness intervention in a sample of 15 adolescents with severe obesity; and 2) to examine the preliminary efficacy of the mindfulness intervention on BMI, emotion regulation, eating and weight-related behaviors, impulsivity, waist circumference, and blood pressure in comparison to the standard of care.
Tipo de estudio
Intervencionista
Inscripción (Actual)
11
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
District of Columbia
-
Washington, District of Columbia, Estados Unidos, 20001
- Children's National Medical Center - IDEAL Clinic
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
12 años a 17 años (Niño)
Acepta Voluntarios Saludables
No
Géneros elegibles para el estudio
Todos
Descripción
Inclusion Criteria:
- between the ages of 12 - 17 years
- a current patient of our affiliated obesity clinic
- have a body mass index (BMI) between 30 and 45 kg/m2.
Exclusion Criteria:
- have a known genetic cause of obesity
- have been diagnosed with a severe intellectual or learning disability
- have been diagnosed with an autism spectrum disorder or current psychosis
- are taking a medication intended to reduce body weight
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Mindfulness
The mindfulness intervention consists of 6 weekly sessions, blending material from the evidence-based Learning to BREATHE and Mindfulness-Based Eating Awareness Training manualized interventions.
Sessions will focus on: experiential mindfulness exercises, such as mindful eating, loving kindness practices, breath awareness, and mindful movement; hunger and satiety awareness; improving responses to emotions; practicing acceptance and being non-judgmental; and tolerating negative feelings and sensations, including those related to hunger and cravings.
Participants will be assigned brief homework exercises (approximately 10 minutes) daily in between appointments.Participants in this arm will also receive the usual care provided by the weight management clinic.
|
Mindfulness refers to the experience of paying attention to the present moment in a nonjudgmental manner.
The mindfulness intervention consists of 6 weekly sessions focused on: experiential mindfulness exercises, such as mindful eating, loving kindness practices, breath awareness, and mindful movement; hunger and satiety awareness; improving responses to emotions; practicing acceptance and being non-judgmental; and tolerating negative feelings and sensations, including those related to hunger and cravings.
Participants will be assigned brief homework exercises (approximately 10 minutes) daily in between appointments.
Participants will receive the recommended standard of medical management of overweight and obesity.
The clinic team conducts a comprehensive evaluation of the patient to assess dietary and activity behavior change needs of each patient and family, as well as obesity-associated comorbidities.
In addition to management of comorbidities, goals for improved physical activity and dietary behaviors are set with the patient and family at each visit.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Number of Sessions Attended by Participant
Periodo de tiempo: 6 weeks post study start date
|
Retention will be tracked via attendance; research staff will take attendance during each assessment period and intervention session to determine the feasibility of retaining participants.
|
6 weeks post study start date
|
|
Participant Satisfaction: Satisfaction Survey
Periodo de tiempo: 6 weeks post study start date
|
We will assess participants' satisfaction with the intervention by having them complete a satisfaction survey at the end of the program to assess perceived helpfulness of the intervention and to elicit feedback on the various components.
Participants respond to 6 questions (e.g., "I enjoyed being a part of this program") on a scale of 1 (strongly disagree) to 5 (strongly agree).
An average across scores will be calculated with higher scores reflecting greater satisfaction.
Possible scores range from 1 to 5.
|
6 weeks post study start date
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Binge Eating - Eating Disorders Examination-Questionnaire (EDEQ).
Periodo de tiempo: Change from Baseline to 6 weeks
|
Participants will report instances of binge eating via items of the Eating Disorders Examination-Questionnaire (EDEQ).
Participants report how often they engaged in binge eating over the past 28 days 0 (no days) to 28 (every day).
Higher scores represent greater eating pathology.
|
Change from Baseline to 6 weeks
|
|
Mindful Attention Awareness Scale-Adolescent (MAAS-A)
Periodo de tiempo: Change from Baseline to 6 weeks
|
Participants rate how frequently they experience episodes of mindless behavior via the Mindful Attention Awareness Scale-Adolescent (MAAS-A).
The MAAS-A is a 15-item measure of dispositional mindfulness.
Participants respond to statements on a scale from 1 (almost always) to 6 (almost never).
Items are summed with scores ranging from 15 to 90, with higher scores representing higher levels of mindfulness.
|
Change from Baseline to 6 weeks
|
|
"Go" Reaction Time - Measure of Inhibitory Control
Periodo de tiempo: Change from Baseline to 6 weeks
|
The Go No Go Task examines inhibitory control via a computerized program.
Participants are instructed to press a button when a certain image is shown on the screen (e.g., a green rectangle, a cross).
They are instructed not to respond when another image is shown on the screen (e.g., a blue rectangle, an X).
Poor inhibitory control is evident by more failures to inhibit responses in the "no go" condition.
Reaction time is the processing speed for correct Go trials.
|
Change from Baseline to 6 weeks
|
|
Body Mass Index (BMI)
Periodo de tiempo: Change from Baseline to 6 weeks
|
Height and weight will be assessed in order to calculate BMI.
|
Change from Baseline to 6 weeks
|
|
Overeating - Eating Disorders Examination-Questionnaire (EDEQ).
Periodo de tiempo: Change from Baseline to 6 weeks
|
Participants report instances of overeating via items of the Eating Disorders Examination-Questionnaire (EDEQ).
Participants report how often they engaged in overeating over the past 28 days 0 (no days) to 28 (every day).
Higher scores represent greater overeating.
|
Change from Baseline to 6 weeks
|
|
Go No Go False Alarm Rate - Measure of Inhibitory Control
Periodo de tiempo: Change from Baseline to 6 weeks
|
The Go No Go Task examines inhibitory control via a computerized program.
Participants are instructed to press a button when a certain image is shown on the screen (e.g., a green rectangle, a cross).
They are instructed not to respond when another image is shown on the screen (e.g., a blue rectangle, an X).
Poor inhibitory control is evident by more failures to inhibit responses in the "no go" condition.
The false alarm rate refers to incorrect No Go trials.
|
Change from Baseline to 6 weeks
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Colaboradores
Publicaciones y enlaces útiles
La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
19 de febrero de 2019
Finalización primaria (Actual)
31 de agosto de 2019
Finalización del estudio (Actual)
1 de junio de 2020
Fechas de registro del estudio
Enviado por primera vez
7 de marzo de 2019
Primero enviado que cumplió con los criterios de control de calidad
12 de marzo de 2019
Publicado por primera vez (Actual)
14 de marzo de 2019
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
14 de abril de 2021
Última actualización enviada que cumplió con los criterios de control de calidad
19 de marzo de 2021
Última verificación
1 de marzo de 2021
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- CNMC Pro00011128
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
NO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .